DiaMedica Therapeutics, Inc. (DMAC)
8.42
-0.08
(-0.94%)
USD |
NASDAQ |
Feb 20, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics SG&A Expense (Quarterly) : 2.596M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| XOMA Royalty Corp. | 9.734M |
| Avantor, Inc. | 392.40M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |